Search Results

Kaneka Corporation has acquired all shares of Japan Medical Device Technology Co., Ltd., a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned subsidiary.

Kaneka Corporation has decided to increase its GMP*1 manufacturing capacity for mRNA*2 in Kaneka Eurogentec S.A., a wholly owned group company in Europe.

Rapid Medical™, a leading developer of advanced neurovascular devices, announced Japanese approval for its TIGERTRIEVER revascularization device.

Kaneka Corporation has released KANEKA RT-PCR Kit SARS-CoV-2, a real-time PCR test kit capable of simultaneously detecting four variants of COVID-19.

Kaneka Corporation received U.S.-FDA*1approval in April 2020 for its new brain aneurysm Embolization Coil*2,and has been marketing it through Kaneka Medical America LLC*3 since September 2020.

Kaneka Eurogentec, an FDA inspected contract development and manufacturing organization, announced that its mRNA manufacturing facility has successfully produced a 25 g batch of mRNA for a US customer.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization received GMP accreditation by the Belgian ministry of health for the GMP manufacturing of messenger RNA.

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the execution of an agreement with Kaneka Eurogentec S.A., an affiliate of Kaneka Corporation, for Eurogentec to manufacture INOVIO’s COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales